(Q33492297)

27 July 2017

title

Predicting neuropathy and reactions in leprosy at diagnosis and before incident events-results from the INFIR cohort study (English)

1 reference

27 July 2017

0 references

9

Einar P Wilder-Smith

0 references

Pramila Barkataki

4

object named as

Pramila Barkataki

0 references

Diana N J Lockwood

10

object named as

Diana N J Lockwood

1 reference

27 July 2017

W Cairns S Smith

1

1 reference

27 July 2017

Peter G Nicholls

2

1 reference

27 July 2017

Loretta Das

3

1 reference

27 July 2017

Sujai Suneetha

5

1 reference

27 July 2017

Lavanya Suneetha

6

1 reference

27 July 2017

Rupendra Jadhav

7

1 reference

27 July 2017

P S S Sundar Rao

8

1 reference

27 July 2017

Wim H van Brakel

11

1 reference

27 July 2017

language of work or name

English

0 references

publication date

11 August 2009

1 reference

PLoS Neglected Tropical Diseases

27 July 2017

published in

1 reference

27 July 2017

volume

3

1 reference

27 July 2017

issue

8

1 reference

27 July 2017

page(s)

e500

1 reference

Creative Commons Attribution 4.0 International

27 July 2017

copyright license

start time

11 August 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Early diagnosis of neuropathy in leprosy--comparing diagnostic tests in a large prospective study (the INFIR cohort study)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716523

The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716523

Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1).

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716523

Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716523

Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716523

The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. III. Neural and other impairments

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716523

Tumor necrosis factor: status in reactions in leprosy before and after treatment

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716523

Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716523

Tumor necrosis factor production in patients with leprosy

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716523

Comparative study of anti-PGL-1, anti-35 kDa and anti-lipoarabinomannan assays for serodiagnosis of leprosy.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716523

The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716523

Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716523

A clinical prediction rule for nerve-function impairment in leprosy patients

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716523

Nerve function impairment in leprosy at diagnosis and at completion of MDT: a retrospective cohort study of 786 patients in Bangladesh

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716523

Ageing and thermal responses during passive heat exposure: sweating and sensory aspects

31 October 2018

1 reference

12 December 2020

Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type-1 reactions in leprosy

1 reference

12 December 2020

Detection of S-100 protein and anticeramide antibodies in leprosy patients by ELISA

1 reference

12 December 2020

The pathology of early leprous neuropathy

1 reference

12 December 2020

Biochemical aspects of Mycobacterium leprae binding proteins: a review of their role in pathogenesis

1 reference

12 December 2020

10.1371/JOURNAL.PNTD.0000500

Identifiers

DOI

1 reference

27 July 2017

1 reference

27 July 2017

1 reference